Business
AbbVie Breaks Ground on New North Chicago Active Pharmaceutical Ingredient Manufacturing Facility
AbbVie (NYSE: ABBV) today announced the start of construction of its new active pharmaceutical ingredient (API) manufacturing plant in North Chicago, Illinois. This is a significant milestone in AbbVie's ongoing efforts to expand its U.S. manufacturing network, capabilities and capacity.
About this update from Abbvie Inc.
[{"type":"list","items":[{"val":[{"type":"text","content":"New state-of-the-art active pharmaceutical ingredient (API) facility will manufacture immunology, oncology and neuroscience medicines","length":133,"tagName":"p"}]},{"val":[{"type":"text","content":"Facility expected to be fully operational and serving patients by 2027","length":70,"tagName":"p"}]},{"val":[{"type":"text","content":"Milestone marks progress on AbbVie's long-term commitment to U.S. manufacturing","length":89,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":292,"olType":false},{"type":"text","content":"NORTH CHICAGO, Ill., Sept. 29, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced the start of construction of its new active pharmaceutical ingredient (API) manufacturing plant in North Chicago, Illinois. This is a significant milestone in AbbVie's ongoing efforts to expand its U.S. manufacturing network, capabilities and capacity.","length":349,"tagName":"p"},{"type":"image","alt":"AbbVie officials participate in a groundbreaking ceremony on September 29, 2025, for AbbVie’s new active pharmaceutical ingredient (API) facility in North Chicago, Illinois. This expansion is part of AbbVie’s commitment to invest more than $10 billion in capital in the U.S. over the next decade.","displaySize":"","headline":null,"caption":"AbbVie officials participate in a groundbreaking ceremony on September 29, 2025, for AbbVie’s new active pharmaceutical ingredient (API) facility in North Chicago, Illinois. This expansion is part of AbbVie’s commitment to invest more than $10 billion in capital in the U.S. over the next decade.","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":267,"url":"https://media.zenfs.com/en/prnewswire.com/7e98232ee357fa8333936a93ec08cfba"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/FmQlJyJA97PMOvbS_R9Qzw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ3MTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/7e98232ee357fa8333936a93ec08cfba","width":400,"height":267}},"href":"https://mma.prnewswire.com/media/2784603/AbbVie_API_facility_Chicago.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":""Today's groundbreaking is an important milestone in AbbVie's ongoing campaign to accelerate biopharmaceutical innovation and manufacturing capabilities in the U.S.," ...